Hepatitis B vaccine is safe and available for people up to 49 years of age
Hepatitis B is a viral disease transmitted from person to person. According to the Ministry of Health, 120,343 cases of the disease were reported in Brazil between 1999> and 2011. Virus infection occurs through unprotected intercourse, blood transfusion or contact with needles, syringes and other contaminated materials, including tattoo needles , acupuncture, dental, surgical or manicure instruments. The virus can also be transmitted from the mother to the baby at the time of delivery and through breastfeeding. The diagnosis is made by means of a specific blood test.
The manifestations are variable, and can vary asymptomatically and with spontaneous cure until fulminant hepatitis, with risk of death. The most critical picture is the chronification and development of liver cirrhosis and liver cancer.
Fortunately, in addition to antiviral treatment, there is an even more effective mechanism for the control of hepatitis B, vaccination.
It has been safe and effective has been available in the Unified Health System since 1989, targeting at-risk groups. The vaccination recommendation for children came up in 1998. In 2011, the National Immunization Program extended the age range for adult vaccination against hepatitis B until, in 2013, vaccination for hepatitis was instituted for all persons up to 49 years of age. age.
The hepatitis vaccine should be taken in three doses. There is no contraindication except when there is a severe allergic reaction to any of the doses of the vaccine. It is applied to the deltoid muscle (in the arm) in adults, and in the thigh in infants. The site of application may get a bit sore in the days following the application, but no other major adverse reactions are expected.
All persons up to the age of 49 should seek the nearest basic health unit to their home and receive the vaccine . The same vaccine is available in private immunization clinics.
The disease can have serious long-term consequences, with a risk of developing liver cancer. The vaccine is safe, effective and accessible to everyone. Take care!
The National Agency of Sanitary Surveillance (Anvisa) suspended one batch of the medicine Pantocal® EV 40 mg lyophilized powder for solution for injection, reporting the presence of glass chip in the medicine. The manufacturer, Eurofarma Laboratorios SA, must immediately stop the distribution, marketing and use of the product from lot 463128 (phases A and B).
Everyone knows someone who has diabetes. Also, according to the research Life Insights: Health Report conducted by the My Life portal, about 1 in 10 people have the disease. This is in line with national statistics: a study published recently by the Ministry of Health indicates that 8.9% of Brazilians claim to live with the condition, which increased 61.